Author of the publication

Improved outcome to two years of very low-birthweight infants: fact or artifact?

, , , , , and . Dev Med Child Neurol, 28 (5): 579--588 (October 1986)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Improvement in outcome for very low birthweight children: apparent or real?, , , , , and . Med J Aust, 157 (3): 154--158 (August 1992)Improved outcome to two years of very low-birthweight infants: fact or artifact?, , , , , and . Dev Med Child Neurol, 28 (5): 579--588 (October 1986)Longitudinal study of very low birthweight infants: impairments, health and distance growth to 14 years of age., , and . Aust Paediatr J, 23 (6): 335--338 (December 1987)Extremely-low-birthweight infants: neurological, psychological, growth and health status beyond five years of age., , , , , and . Med J Aust, 147 (10): 476--481 (November 1987)Outcome to 8 years of infants less than 1000 g birthweight: relationship with neonatal ventilator and oxygen therapy., , , , , , , and . J Paediatr Child Health, 27 (3): 184--188 (June 1991)Mortality and two year outcome of infants of birthweight 500-1500 g: relationship with neonatal cerebral ultrasound data., , , , , , , and . Aust Paediatr J, 21 (4): 253--259 (November 1985)Cesarean section or vaginal delivery at 24 to 28 weeks' gestation: comparison of survival and neonatal and two-year morbidity., , , , , , and . Obstet Gynecol, 66 (2): 149--157 (August 1985)Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight., , , , , , and . J Paediatr Child Health, 36 (1): 47--50 (February 2000)The obstetrician and the extremely immature fetus (24-26 weeks): outcome to 5 years of age., , , , , , and . Aust N Z J Obstet Gynaecol, 34 (4): 421--424 (August 1994)Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions., , , , and . Obstet Gynecol, 81 (6): 931--935 (June 1993)